Related Experiment Video
Updated: Oct 5, 2025

Passive Administration of Monoclonal Antibodies Against H. capsulatum and Others Fungal Pathogens
Published on: February 14, 2011
Histoplasmosis in African children: clinical features, diagnosis and treatment
Bassey Ewa Ekeng1, Kevin Edem2, Patricia Akintan3
1Department of Medical Microbiology and Parasitology, University of Calabar Teaching Hospital, Calabar 540271, Nigeria.
Insights
This review highlights histoplasmosis in African children, finding disseminated disease common, often affecting skin and bones. It emphasizes the need for increased awareness and diagnosis beyond common pediatric conditions in Africa.
Area of Science:
- Medical Mycology
- Pediatric Infectious Diseases
- Tropical Medicine
Background:
- Histoplasmosis reviews predominantly focus on adult populations, with limited data on pediatric cases in Africa.
- Histoplasmosis in African children presents unique clinical challenges and diagnostic considerations.
Purpose of the Study:
- To review and summarize case reports of histoplasmosis in African children from 1950-2021.
- To highlight clinical features, diagnostic methods, and outcomes of pediatric histoplasmosis in Africa.
- To underscore the importance of considering histoplasmosis in the differential diagnosis of pediatric illnesses in Africa.
Main Methods:
- Systematic review of 44 published case reports of histoplasmosis in African children.
- Analysis of epidemiological data, causative species (Histoplasma capsulatum var. duboisii predominantly), clinical presentations, diagnostic modalities, and treatment outcomes.
- Review of geographical distribution across African regions.
Main Results:
- Central and Western Africa reported the highest number of cases. Histoplasma capsulatum var. duboisii was the most common etiological agent.
- Disseminated histoplasmosis (56.8%) was prevalent, with frequent involvement of skin (65.9%), bones (45.5%), and lymph nodes (34.1%).
- Histopathology was the primary diagnostic tool (75%). Amphotericin B and ketoconazole were common treatments, with a 61.4% favorable outcome rate. Misdiagnosis as tuberculosis, cancer, and other conditions was noted.
Conclusions:
- Histoplasmosis in African children often presents as disseminated disease with extrapulmonary manifestations, particularly affecting the skin and bones.
- There is a critical need for enhanced diagnostic awareness and capacity for histoplasmosis in African pediatric healthcare settings.
- Pediatricians in Africa should broaden their differential diagnoses to include histoplasmosis, especially when common pediatric diseases are suspected but do not respond to treatment.
Abstract:
Most of the reviews on histoplasmosis documented in literature have been in the adult population. Very few studies highlight the peculiarities associated with histoplasmosis in Africa especially in the pediatric population. This review addresses the above concerns with clinical summaries and diagnosis of some case reports of histoplasmosis in African children. We highlighted 44 case reports of histoplasmosis in African children (1950-2021) distributed across Western Africa (38.6%, n = 17), Eastern Africa (9.1%, n = 4), Southern Africa (9.1%, n = 4), and Central Africa (43.2%, n = 19). No case report was found from Northern Africa. The age range was 1-17 years, with a mean of 9.2. Of the 44 case reports, 8 cases (18.2%, 8/44) were caused by Histoplasma capsulatum var capsulatum, 33 cases (75%, 33/44) were caused by Histoplasma capsulatum var duboisii, and specie identification was not found in 3 cases. Only three (6.8%) cases were HIV positive; 56.8% (25/44) were disseminated histoplasmosis, pulmonary histoplasmosis accounted for just one case (2.3%, 1/44). Extrapulmonary presentation included skin lesions (ulcers, fistulas, nodules, patches, pigmentations, papules, and abscesses), bone lesions, osteoarthritis, and fractures. The commonest sites affected were skin (n = 29, 65.9%), bones (n = 20, 45.5%), and lymph nodes (n = 15, 34.1%). Histopathology was the commonest diagnostic method (n = 33, 75%). Amphotericin B was first-line therapy in 45.5% of the cases (n = 20) followed by ketoconazole (20.5%, n = 9); 27 cases (61.4%) had favorable outcomes, 8 cases (18.2%) had fatal outcomes, while in 9 cases, the outcome was not revealed. This review revealed several cases of histoplasmosis misdiagnosed as other conditions including tuberculosis (n = 3, 6.8%), pneumonia (n = 1, 2.3%), cancers (n = 4, 9.1%), nephritic syndrome (n = 1, 2.3%), leishmaniasis (n = 1, 2.3%), and hyperreactive malarial splenomegaly syndrome (n = 1, 2.3%). In addition, histoplasmosis was not considered in some case reports even when symptoms were suggestive. Diagnosis of histoplasmosis was made at autopsy with postmortem findings suggestive of histoplasmosis (n = 3, 6.8%). This report highlights the need for a paradigm shift on the part of pediatricians in Africa. They need to look beyond clinical conditions considered common in our environment for this age group and evaluate for other diseases including histoplasmosis.
Related Concept Videos
Fungal Phylum Microsporidia
Immunodeficiency Diseases
There are three main causes of immunodeficiency...
Pulmonary Tuberculosis V
Latent tuberculosis infection occurs when TB bacteria are present in a person's body, but are not causing illness or symptoms. It is not contagious, and preventive treatment is crucial to avoid the...
Pulmonary Tuberculosis I
Causative Organism
The primary infectious agent causing tuberculosis is Mycobacterium tuberculosis, a slow-growing, acid-fast, aerobic rod that exhibits sensitivity to heat and ultraviolet light. Instances of Mycobacterium bovis and Mycobacterium avium contributing to the development of TB infection are rare.
Mode of...
Pulmonary Tuberculosis III
The first classification is based on the development of the disease, and it includes the following categories:

